LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

被引：0
|
作者：
Amanda E. D. Van Swearingen
Marni B. Siegel
Allison M. Deal
Maria J. Sambade
Alan Hoyle
D. Neil Hayes
Heejoon Jo
Paul Little
Elizabeth Claire Dees
Hyman Muss
Trevor Jolly
Timothy M. Zagar
Nirali Patel
C. Ryan Miller
Joel S. Parker
J. Keith Smith
Julie Fisher
Nikita Shah
Lisle Nabell
Rita Nanda
Patrick Dillon
Vandana Abramson
Lisa A. Carey
Carey K. Anders
机构：
[1] University of North Carolina at Chapel Hill,Lineberger Comprehensive Cancer Center
[2] Carolinas Medical Center,West Cancer Center
[3] MD Anderson Orlando,undefined
[4] University of Alabama,undefined
[5] University of Chicago,undefined
[6] University of Virginia,undefined
[7] Vanderbilt University,undefined
[8] University of Tennessee,undefined
来源：
Breast Cancer Research and Treatment | 2018年 / 171卷
关键词：
Breast cancer; Brain metastases; Metastases; PI3K, MEK; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 648
页数：11
相关论文
共 50 条
  • [21] Neratinib in HER2-Positive Breast Cancer With Brain Metastases
    Dekker, Tim Johannes Adrianus
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03) : 251 - +
  • [22] Treatment of brain metastases of HER2-positive breast cancer
    Heudel, P.
    Tredan, O.
    Cassier, P.
    Ray-Coquard, I.
    Guastalla, J. -P.
    Bachelot, T.
    ONCOLOGIE, 2012, 14 (01) : 41 - 44
  • [23] A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
    Chen, Tom Wei-Wu
    Yeh, Dah-Cherng
    Chao, Tsu-Yi
    Lin, Ching-Hung
    Chow, Louis Wing-Cheong
    Chang, Dwan-Ying
    Hsieh, Yao-Yu
    Huang, Shu-Min
    Cheng, Ann-Lii
    Lu, Yen-Shen
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (03) : 242 - 247
  • [24] Phase II Southwest Oncology Group study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer
    Kash, J.
    Barlow, W. E.
    Albain, K. S.
    Gralow, J. R.
    Lew, D.
    Flaherty, L. E.
    Royce, M. E.
    Hortobagyi, G. N.
    Livingston, R. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer
    Chan, Arlene
    Conte, Pier-Franco
    Petruzelka, Lubos
    Tubiana-Mathieu, Nicole
    Ganju, Vinod
    Llombart, Antonio
    Espie, Marc
    Majois, Francoise
    Gil, Miguel Gil
    Vaissiere, Nathalie
    Villanova, Gustavo
    ANTICANCER RESEARCH, 2013, 33 (06) : 2657 - 2664
  • [26] Phase II study of trastuzumab with irinotecan in HER2-positive gastric cancer previously treated with trastuzumab
    Hatanaka, Kazuteru
    Kawamoto, Yasuyuki
    Yuki, Satoshi
    Meguro, Takashi
    Uebayashi, Minoru
    Abe, Masakazu
    Nakamura, Michio
    Okuda, Hiroyuki
    Sakata, Yuh
    Komatsu, Yoshito
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer
    Yardley, Denise A.
    Daniel, Davey
    Stipanov, Michael
    Drosick, D. Randolph
    Mainwaring, Mark
    Peyton, James
    Shastry, Mythili
    Hainsworth, John D.
    CANCER INVESTIGATION, 2010, 28 (08) : 865 - 871
  • [28] Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis
    Oberkampf, Florence
    Gutierrez, Maya
    Grati, Olfa Trabelsi
    Le Rhun, Emilie
    Tredan, Olivier
    Turbiez, Isabelle
    Kadi, Amir
    Dubot, Coraline
    Taillibert, Sophie
    Vacher, Sophie
    Bonneau, Claire
    NEURO-ONCOLOGY, 2023, 25 (02) : 365 - 374
  • [29] Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
    Takashima, Tsutomu
    Nakayama, Takahiro
    Yoshidome, Katsuhide
    Kawajiri, Hidemi
    Kamigaki, Shunji
    Tsurutani, Junji
    Arai, Takashi
    Ito, Toshikazu
    Komoike, Yoshihumi
    Doi, Takako
    Masuda, Norikazu
    Miyauchi, Keisuke
    Miyoshi, Yasuo
    Sakamoto, Junichi
    Morita, Satoshi
    Taguchi, Tetsuya
    ANTICANCER RESEARCH, 2014, 34 (07) : 3583 - 3588
  • [30] Phase II trial of preoperative vinorelbine/trastuzumab (VH) or docetaxel/carboplatin/trastuzumab (TCH) in HER2-positive breast cancer with analysis of resistance mechanisms.
    Krop, I. E.
    Flores, L.
    Tuck, D. P.
    Ryan, P. D.
    Partridge, A. H.
    Morganstern, D.
    Najita, J.
    Iezon-Geyda, K.
    Winer, E. P.
    Harris, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345